John Rotrosen

Also affiliated with New York University

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder”.

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder

JAMA Psychiatry(2022)10.1001/jamapsychiatry.2022.2096

N/A

6.1DataRank · unranked

670 citations

Stephen Ross, Snehal Bhatt, Tara Baron, Alyssa A. Forcehimes, Eugene Laska +8 more

Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.106976

N/A

0.761DataRank · unranked

24 citations

Sarah E. Mennenga, Lindsey T. Owens, Samantha K. Podrebarac, Tara Baron, John Rotrosen +4 more

Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study

Addiction Science & Clinical Practice(2021)10.1186/s13722-021-00224-y

N/A

0.447DataRank · unranked

9 citations

John Rotrosen, Phoebe Gauthier, Gail D’Onofrio, David A. Fiellin, Lisa A. Marsch +12 more

Optimizing the use of ketamine to reduce chronic postsurgical pain in women undergoing mastectomy for oncologic indication: study protocol for the KALPAS multicenter randomized controlled trial

Trials(2024)10.1186/s13063-023-07884-y

N/A

0.296DataRank · unranked

5 citations

Lisa Doan, Deborah Axelrod, John Rotrosen, Binhuan Wang, Hyung Park +6 more

Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107148

N/A

0.216DataRank · unranked

3 citations

Matisyahu Shulman, Onumara Opara, Kenzie M. Potter, Delia Voronca, Hiwot M. Tafessu +12 more

Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients

Addiction Science & Clinical Practice(2023)10.1186/s13722-023-00404-y

N/A

0DataRank · unranked

14 citations

Bethany McLeman, Trip Gardner, Noah Nesin, Vijay Amarendran, Sarah Farkas +9 more

Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder

Addiction(2024)10.1111/add.16473

N/A

0DataRank · unranked

11 citations

Sara Lodi, Heather Hsu, Benjamin J. Bovell-Ammon, Shapei Yan, Dana Bernson +7 more

Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone on Treatment Interruption: Comparing Findings from a Reanalysis of the X:Bot Rct and Harmonized Target Trial Emulation Using Population-Based Observational Data

SSRN Electronic Journal(2024)10.2139/ssrn.4933445

N/A

0DataRank · unranked

0 citations

Shapei Yan, Benjamin J. Bovell-Ammon, Paul J. Christine, Heather Hsu, Dana Bernson +7 more

Extended-release naltrexone versus buprenorphine-naloxone to treat opioid use disorder among black adults

Addictive Behaviors(2020)10.1016/j.addbeh.2020.106514

N/A

0DataRank · unranked

7 citations

LaTrice Montgomery, A. Kathleen Burlew, Aimee Campbell, Jennifer Scodes, Martina Pavlicová +3 more

A clinical trial loses access to some of its experimental treatment conditions: What can be done?

Journal of Substance Use and Addiction Treatment(2025)10.1016/j.josat.2025.209854

N/A

0DataRank · unranked

0 citations

Matisyahu Shulman, R D Weiss, Patricia Novo, Scott E. Provost, Michael Otterstatter +4 more

Reductions in tobacco use in naltrexone, relative to buprenorphine-maintained individuals with opioid use disorder: Secondary analysis from the National Drug Abuse Treatment Clinical Trials Network

Journal of Substance Abuse Treatment(2021)10.1016/j.jsat.2021.108489

N/A

0DataRank · unranked

7 citations

Theresa Winhusen, Jennifer Scodes, Martina Pavlicová, Dylanne Twitty, Aimee Campbell +4 more

Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.44955

N/A

0DataRank · unranked

57 citations

Ryan McCormack, E. Jennifer Edelman, Edouard Coupet, Nicolle Toledo, Phoebe Gauthier +15 more

Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene

European Journal of Clinical Pharmacology(2022)10.1007/s00228-022-03302-5

N/A

0DataRank · unranked

3 citations

Robrina Walker, David P. Graham, Ellen M. Nielsen, Sara Hamon, Maureen Hillhouse +10 more

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Drug and Alcohol Dependence Reports(2022)10.1016/j.dadr.2022.100100

N/A

0DataRank · unranked

2 citations

Tse‐Hwei Choo, Dikla Shmueli‐Blumberg, Martina Pavlicová, Jacquie King, Marc Fishman +9 more